North America (change)      
Cognos

Cognos Home > News Highlights > 2002 News Releases > News Release
Cognos Reports Record
Third Quarter Results

— Record Business Intelligence Revenue
Drives Strong Earnings Growth —

Ottawa, ON and Burlington MA, December 19, 2002—Cognos Incorporated (Nasdaq: COGN; TSX: CSN - all figures in U.S. dollars), the world leader in business intelligence solutions, today announced results for its third quarter of fiscal year 2003, which ended November 30, 2002.

Revenue for the quarter was $138.1 million, an increase of 11 percent compared with revenue of $124.2 million for the same period last year. Net income was $19.9 million or $0.22 per share. This is an increase of 50 percent compared with net income of $13.3 million or $0.15 per share in the third quarter of last year.

Revenue for the nine-month period ended November 30, 2002 was $387.3 million, compared with $348.5 million for the same period last year. Net income for the first nine months of this year was $43.6 million or $0.48 per share, compared with $9.3 million or $0.10 per share, including restructuring charges of $12.8 million, for the corresponding period last year. Excluding restructuring charges, net income for the first nine months of last year was $18.3 million or $0.20 per share.1

Total business intelligence (BI) revenue achieved strong growth in the quarter, continuing its momentum. BI revenue reached $130.3 million, an increase of 14 percent from the third quarter of last year. BI license revenue increased 7 percent to $60.3 million, compared with $56.5 million for the same period last year. BI support revenue increased 26 percent to reach $47.1 million, compared with $37.5 million last year. The strong growth in this important, recurring revenue stream underscores the high value our customers place on the Cognos enterprise BI solution.

Highlights of the Quarter

  • Double-digit percentage growth for BI revenue in all of our three major geographies - US, Europe and Asia/Pacific

  • Analytic Applications revenue growth of 68 percent year over year to $10.4 million

  • Contracts greater than $200,000 increased 17 percent year over year to 74; contracts greater than $50,000 increased 14 percent to 458

  • Continued operating margin expansion to 20.3 percent

  • Outstanding customer response to Cognos Series 7 and Corporate Performance Management: 10,000 customers attended Cognos Enterprise 2002 User Days in 29 cities

  • Cognos Series 7 named best overall BI solution by META Group SPEX

  • Independent study by Nucleus Research revealed high customer satisfaction and return on investment for the Cognos BI solution

Cognos continued to strengthen its balance sheet during the quarter. Cash flow was $6.8 million, net of $6.9 million expended to repurchase stock in the quarter. The Company had $338.1 million in cash, cash equivalents, and short-term investments at the end of the third quarter. Days sales outstanding for accounts receivable were 67 days, based on ending balances, compared with 73 days for the same period last year.

"The third quarter was rock solid for Cognos," said Cognos CEO Ron Zambonini. "We delivered excellent results across the board in a tough market. The Cognos team is performing and our customers are responding to the superior value proposition of the Cognos solution. We continue to demonstrate our leadership in the BI market by driving excellent momentum.

"Leading organizations throughout the world made significant commitments to our enterprise business intelligence solution again this quarter. The Company was awarded four contracts greater than $1 million. More indicative of the strong market acceptance of the Cognos solution was the 17 percent increase in contracts greater than $200,000. Many of our largest customers were again represented in these enterprise-scale contracts. These customers know through first-hand experience the proven and predictable ROI of the Cognos solution, and include leading corporations like American Express, AT&T, BMW, Federal Express, Ford Motor Company, General Electric, GlaxoSmithKline, Manulife Financial, Merrill Lynch, Penn Mutual Life, Pfizer, Shell Oil, Toyota, and the U.S. Air Force.

"Our new product pipeline is driving a clear competitive advantage for Cognos," continued Mr. Zambonini. "Cognos Series 7 and analytic applications continue to build momentum. Series 7 is spurring our competitive success in new accounts, and the robust uptake within our existing customer base provides additional up-sell and cross-sell opportunities. Cognos Metrics Manager was released on schedule on November 27th. I've never seen a more positive customer response to a Cognos solution than for Metrics Manager. And I have never been more positive about the position and prospects for Cognos."

Business Outlook
Management offers the following outlook for the fourth quarter of fiscal 2003, ending February 28, 2003, excluding the impact of the planned acquisition of Adaytum, Inc.:

  • Revenue is expected to be in the range of $155 million to $157 million;

  • Diluted earnings per share are expected to be in the range of $0.28 to $0.29.

Management offers the following outlook for the full fiscal year 2003, excluding the impact of the planned acquisition of Adaytum, Inc.:

  • Revenue is expected to be in the range of $542 million to $544 million;

  • Diluted earnings per share are expected to be in the range of $0.76 to $0.77.

Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

This press release contains forward-looking statements relating to, among other things, the Company's expectations concerning future revenues and earnings, business outlook and business momentum; the demand for the Company's current and future products; the Company's ability to deliver business intelligence solutions that respond to changing market requirements; the Company's ability to compete in an intensely competitive marketplace; and the soundness of the Company's business model and technology strategies.

These forward-looking statements are neither promises nor guarantees, but involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Factors that may cause such differences include, but are not limited to: the Company's ability to maintain revenue growth or to anticipate a decline in revenue from any of its products or services; the Company's ability to develop and introduce new products and enhancements in the BI software market; rapid technological change in the business intelligence software market; new product introductions and enhancements by competitors; the Company's ability to compete in an intensely competitive market; the Company's ability to select and implement appropriate business models and strategies; the Company's reliance on partners and other third party distribution channels to market and distribute its products; fluctuations in its quarterly and annual operating results based on historical patterns, which may cause its stock price to fluctuate or decline; the impact of global economic conditions on the Company's business and the Company's ability to implement timely and appropriate remedial measures; unauthorized use of the Company's intellectual property; claims by third parties that the Company's software infringes their intellectual property; the risks inherent in international operations, such as currency exchange rate fluctuations; the Company's ability to identify, hire, train, motivate, and retain highly qualified management and other key personnel; and the Company's ability to identify, pursue, and complete acquisitions which could divert management attention and financial resources and not produce desired business results; as well as the risk factors discussed in the Company's most recent Annual Report on Form 10-K filed with the United States Securities and Exchange Commission. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statement to reflect any change in its expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

Cognos will present the Company's financial results for the third quarter fiscal year 2003 and discuss expectations for the future at 5:15 p.m. Eastern Time, today, December 19, 2002. The conference call may be accessed at 416-640-1907. The Webcast may be accessed at http://www.cognos.com/company/investor/events/fy03q3/index.html.

###

Cognos and the Cognos logo are trademarks or registered trademarks of Cognos Incorporated in the United States and/or other countries.

1 Pro forma information is provided for greater comparability regarding Cognos' ongoing operating performance and is unlikely to be comparable to pro forma information provided by other issuers. A reconciliation of the Cognos U.S. GAAP information to the pro forma information is provided in the table that follows.



RECONCILIATION OF PRO-FORMA INFORMATION:

  Three months ended
November 30,
Nine months ended
November 30,
  2002 2001 2002 2001
 

Net Income:
Reported net income $19,929 $13,286 $43,579 $9,288 
Special charges (included in operating expenses) 12,798 
Tax effect on special charges (3,775)
 



Pro-forma net income $19,929 $13,286 $43,579 $18,311 
 



Diluted net income per share:
Reported net income $0.22 $0.15 $0.48 $0.10 
Special charges (after tax) 0.10 
 



Pro-forma net income $0.22 $0.15 $0.48 $0.20 
 



Weighted average number of shares (000s):
Basic 87,845 87,488 87,916 87,840 
 



Diluted 89,882 89,456 90,487 89,980 
 




SUPPLEMENTARY INFORMATION:

  FY2002 FY2003
 

  Q3 Q4 Q1 Q2 Q3

Revenue Statistics ($000s)
  BI 114,140  133,567  111,598  120,576  130,299 
  Application development tools 10,041  9,225  8,532  8,528  7,775 
 
  BI License 56,526  73,018  47,966  52,988  60,346 
 
  North America 77,141  87,501  78,913  80,768  83,952 
  Europe 38,440  45,341  33,717  39,255  43,750 
  Asia/Pacific 8,600  9,950  7,500  9,081  10,372 
 
Year-Over-Year Revenue Growth Statistics
  BI 1%  1%  13%  13%  14% 
  Application development tools (15%) (24%) (9%) (11%) (23%)
 
  BI License (8%) (4%) 16%  10%  7% 
 
  North America (5%) (4%) 18%  11%  9% 
  Europe 10%  2%  1%  10%  14% 
  Asia/Pacific (1%) 22%  0%  18%  21% 
 
Other Statistics
Cash, cash equivalents and short-term investments ($000s) 268,117  314,529  338,259  331,261  338,103 
Days sales outstanding 73  72  60  59  67 
Total employees 2,546  2,598  2,649  2,684  2,714 



COGNOS INCORPORATED
CONSOLIDATED STATEMENTS OF INCOME


(US$000s except share amounts, U.S. GAAP)
(Unaudited)


 

Three Months Ended
November 30,
Nine Months Ended
November 30,
 

2002   2001    2002   2001   

Revenue
   Product license $ 62,223   $ 59,114    $167,097   $152,835   
   Product support 52,853   44,578    152,269   129,005   
   Services 22,998   20,489    67,942   66,670   

Total revenue 138,074   124,181    387,308   348,510   

Operating expenses
   Cost of product license 722   847    2,170   2,915   
   Cost of product support 5,240   3,825    14,682   11,981   
   Selling, general, and administrative 85,850   84,943    253,677   259,127   
   Research and development 18,264   17,579    56,991   55,424   
   Special charges —   —    —   12,798   

Total operating expenses 110,076   107,194    327,520   342,245   

Operating income 27,998   16,987    59,788   6,265   
Interest expense (211)  (88)   (442)  (257)  
Interest income 1,521   1,947    4,741   7,167   

Income before taxes 29,308   18,846    64,087   13,175   
Income tax provision 9,379   5,560    20,508   3,887   

Net income $ 19,929   $ 13,286    $ 43,579   $  9,288   

Net income per share
   Basic $0.23   $0.15    $0.50   $0.11   

   Diluted $0.22   $0.15    $0.48   $0.10   

Weighted average number of shares (000s)
   Basic 87,845   87,488    87,916   87,840   

   Diluted 89,882   89,456    90,487   89,980   


COGNOS INCORPORATED
CONSOLIDATED BALANCE SHEETS


(US$000s, U.S. GAAP)

  November 30, 
2002 
February 28, 
2002 

Assets (Unaudited)  
Current assets
  Cash and cash equivalents $176,542  $192,900 
  Short-term investments 161,561  121,629 
  Accounts receivable 102,397  114,059 
  Inventories 566  537 
  Prepaid expenses 6,285  6,765 
  Deferred tax assets 5,759  6,404 

  453,110  442,294 
Fixed assets 58,586  59,008 
Goodwill 15,523  15,230 
Intangible assets 3,262  5,620 

  $530,481  $522,152 

Liabilities
Current liabilities
  Accounts payable $ 22,678  $ 26,387 
  Accrued charges 25,771  34,210 
  Salaries, commissions, and related items 39,780  37,453 
  Income taxes payable 2,936  6,167 
  Deferred revenue 99,607  110,504 

  190,772  214,721 
Long-term liabilities 3,440  9,131 
Deferred income taxes 6,687  3,127 

  200,899  226,979 

Stockholders’ Equity
Capital stock
  Common shares
      (November 30, 2002 - 87,863,382;
       February 28, 2002 - 87,997,220)

160,373  151,637 
Retained earnings 183,962  158,762 
Accumulated other comprehensive income (14,753) (15,226)

  329,582  295,173 

  $530,481  $522,152 


COGNOS INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS


(US$000s, U.S. GAAP)
(Unaudited)


  Three months ended
November 30,
Nine months ended
November 30,

  2002   2001   2002   2001  

Cash provided by (used in) operating activities
   Net income $ 19,929   $ 13,286   $ 43,579   $  9,288  
   Non-cash items
      Depreciation and amortization 5,242   8,053   15,247   22,581  
      Amortization of deferred stock-based compensation 148   504   518   1,658  
      Amortization of other deferred compensation 119   606   415   1,938  
      Deferred income taxes 4,389   (309)  3,659   (2,127) 
      Loss on disposal of fixed assets 8   43   109   583  

  29,835   22,183   63,527   33,921  
   Change in non-cash working capital
      Decrease (increase) in accounts receivable (18,157)  (6,116)  15,642   44,870  
      Decrease (increase) in inventory 203   48   (12)  192  
      Decrease in prepaid expenses 1,484   366   867   1,911  
      Decrease (increase) in income tax assets —   2,768   —   (5,526) 
      Increase (decrease) in accounts payable 4,259   (1,631)  (4,458)  (3,745) 
      Increase (decrease) in accrued charges (355)  3,911   (9,755)  9,899  
      Increase in salaries, commissions, and related items 3,390   3,410   935   5,944  
      Increase (decrease) in income taxes payable 154   (144)  (3,045)  (16,747) 
      Decrease in deferred revenue (5,484)  (2,123)  (14,903)  (10,693) 

  15,329   22,672   48,798   60,026  

Cash provided by (used in) investing activities
   Maturity of short-term investments 19,851   56,557   190,232   235,743  
   Purchase of short-term investments (139,146)  (83,144)  (228,789)  (232,035) 
   Additions to fixed assets (3,559)  (2,026)  (11,328)  (10,401) 

  (122,854)  (28,613)  (49,885)  (6,693) 

Cash provided by (used in) financing activities
   Issue of common shares 4,106   1,645   9,831   7,073  
   Repurchase of shares (6,850)  (9,994)  (19,992)  (19,992) 
   Decrease in long-term debt and long-term liabilities (2,361)  (806)  (5,464)  (645) 

  (5,105)  (9,155)  (15,625)  (13,564) 

Effect of exchange rate changes on cash 72   (977)  354   (826) 

Net increase (decrease) in cash and cash equivalents (112,558)  (16,073)  (16,358)  38,943  
Cash and cash equivalents, beginning of period 289,100   170,309   192,900   115,293  

Cash and cash equivalents, end of period 176,542   154,236   176,542   154,236  
Short-term investments, end of period 161,561   113,881   161,561   113,881  

Cash, cash equivalents, and short-term investments, end of period $338,103   $268,117   $338,103   $268,117  



Note to Editors:
Copies of previous Cognos press releases and Corporate and product information are available on Cognos' Web site at http://www.cognos.com, and at PR Newswire's site at http://www.prnewswire.com.

In The News


  Earnings Annoucement